Edenred (EDNMY) 12.2500 $EDNMY The Weekender Aviate -

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Edenred (EDNMY) 12.2500 $EDNMY

The Weekender
Aviate - at Seeking Alpha - Sun Jun 21, 4:38AM CDT
Not the anatomy of a market top Another week passes with Greece dominating the media and influencing investor psyches. While we cannot profess to predict the outcome, we can posit our views on the market and on our themes and stocks. Given ongoing...
UTX: 110.18 (+1.26), SPY: 207.48 (+2.58), SAP: 72.27 (+2.46), FOX: 32.54 (+0.60), LBTYA: 50.86 (+1.87), DIA: 177.41 (+2.15), PHG: 26.26 (+1.11), FCAU: 14.47 (+0.53), VOD: 36.46 (+1.07), NVO: 57.68 (+2.91), SFUN: 7.51 (-0.04)

Edenred México Chooses INETCO Insight for Real-time Transaction Monitoring
PRWeb - Tue May 19, 5:30AM CDT
INETCO(R) Systems Ltd. (http://www.inetco.com), a leading provider of real-time transaction monitoring and customer analytics solutions, today announced that Edenred México S.A. de C.V. has incorporated the INETCO Insight(R) software platform.

Global Blue Announces Jacques Stern as Chief Executive Officer
PR Newswire Europe - Mon May 18, 12:57AM CDT
-- Stern brings extensive experience in merchant solutions and digital payment technologies, most recently as CEO of Edenred SA

InComm Partners with Edenred UK to Launch a Mobile, Real Time Digital Delivery Solution for Gift Cards
PR Newswire Europe - Thu Dec 18, 2:01AM CST
-- Real Time Gift Cards now available through Edenred Employee Benefit Programs

Edenred Study Finds up to One Third of Christmas Reward Budget Is Wasted by Employers
PR Newswire Europe - Wed Nov 26, 7:48AM CST
LONDON, September 30, 2014 /PRNewswire/ --

Edenred Commuter Benefit Solutions Teams up with Chicago Bike Share System, Divvy, to Promote Bike Commuting
Business Wire - Mon Nov 03, 12:40PM CST
Edenred Commuter Benefit Solutions, the nation's leading provider of commuter benefits, has partnered with Chicago's new bike share system, Divvy, in hopes to get more people in the Chicago area bike commuting. The partnership will allow organizations enrolled in Edenred Commuter Benefit Solutions to purchase a Divvy membership at a discounted rate of $65, regularly $75.

Edenred Commuter Benefit Solutions Applauds the Passing of the Affordable Transit Act
Business Wire - Tue Oct 21, 8:27AM CDT
Edenred Commuter Benefit Solutions, the nation's leading provider of commuter benefits, is thrilled about the passing of New York City Council Member, Daniel Garodnick's Affordable Transit Act, a bill making pre-tax commuter benefits a requirement for all NYC-area businesses with 20 or more employees.

Best European Stock Ideas Today
Aviate - at Seeking Alpha - Thu Oct 16, 2:17PM CDT
1. Trader comment 2. Deflation and the scarcity of Yield 3. But not all yields… 4. Swedish Match: sell-off overdone 5. Quality on sale. We buy weakness in the following: 6. Novartis: immunotherapy and their cure for cancer...
SAP: 72.27 (+2.46), NVO: 57.68 (+2.91), NVS: 103.22 (+3.20)

Edenred Commuter Benefit Solutions and ParkWhiz to Drive Savings to Your Daily Commute
Business Wire - Tue Sep 30, 12:14PM CDT
Edenred Commuter Benefit Solutions, the nation's leading provider of commuter benefits, has partnered with ParkWhiz, Inc., the industry leader in online parking.

Labinal Power Systems Partner With Edenred to Deliver New Employee Benefit Scheme
PR Newswire Europe - Wed Aug 20, 6:25AM CDT
LONDON, August 20, 2014 /PRNewswire/ --

Edenred Enters Into an Alliance with American Express in Mexico
PR Newswire Europe - Thu Aug 07, 5:03AM CDT
LONDON, August 7, 2014 /PRNewswire/ --
AXP: 77.31 (+0.97)

Edenred Commuter Benefit Solutions Announces Annual MetroCard for NYC Customers
Business Wire - Mon Jul 21, 11:44AM CDT
Edenred Commuter Benefit Solutions, the leading provider of commuter benefits, is proud to announce a new product in their already robust catalog of commuter offerings, the Annual MetroCard(R)*.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 84

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 21

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 299

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 175

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 98

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Schouw & Co.'s Share Buy-Back Strategy for 2025

Updated Category News Views 153

Overview of Schouw & Co.'s Share Buy-Back Program Schouw & Co. has launched an exciting share buy-back initiative, aiming to enhance shareholder value significantly. This program began on May 5, 2025, and is designed to repurchase shares totaling up to DKK 120 million. This investment runs until December 31, 2025, reflecting the company's commitment to its shareholders....

Continue Reading
Schneider National Plans to Reveal Q3 2024 Earnings Soon

Updated Category News Views 45

Schneider National to Report Third Quarter 2024 Earnings Schneider National, Inc. (NYSE: SNDR), a leader in transportation and logistics services, has announced that it will release its third quarter 2024 earnings report on a future date, ahead of the market opening. This announcement is significant as it highlights the company’s continued focus on financial...

Continue Reading
A Closer Look at BioAge Labs: Legal Challenges Ahead

Updated Category News Views 206

Understanding the Legal Landscape of BioAge Labs Investors in BioAge Labs, Inc. have faced new uncertainties as the clinical-stage biopharmaceutical company becomes entangled in legal challenges. As the firm moves forward in its mission to develop innovative therapies aimed at combating metabolic diseases, significant developments have emerged that every investor should...

Continue Reading
Celebrating the Fusion of Science and Cinema at Starmus 2025

Updated Category News Views 202

Fusion of Science and Cinema at Starmus Festival The Starmus Festival is a unique event that intertwines science and art, culminating in extraordinary dialogues and presentations. Recently, renowned director Christopher Nolan was awarded the prestigious Stephen Hawking Medal for Science Communication during this remarkable celebration. This accolade is not just an honor...

Continue Reading
Millicom Takes Steps to Enhance Transparency in Holdings

Updated Category News Views 82

Millicom Takes Steps to Enhance Transparency in Holdings Millicom International Cellular S.A., commonly recognized as Tigo, is making significant strides in open communication and compliance by submitting regulatory notifications regarding major shareholder holdings. This initiative reinforces their commitment to transparency and regulatory excellence in the ever-evolving...

Continue Reading